Market Overview

Benzinga's M&A Chatter for Monday September 26, 2016


The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday September 26, 2016:


Disney Said to Work With Advisor on Bid for Twitter

The Rumor:
Shares of Twitter (NYSE: TWTR) spiked higher Monday following a report from Bloomberg, that Disney (NYSE: DIS) has hired an advisor and may bid for the social media company. Disney is the latest potential buyer mentioned in the past week, joining Alphabet (NASDAQ: GOOGL) and, inc. (NYSE: CRM). Later, CNBC's David Faber said Microsoft (NASDAQ: MSFT) was a possible bidder, while Facebook (NASDAQ: FB) was not likely interested. Faber said a deal could happen in the next 30 to 45 days.

Twitter closed at $23.37 on Monday, up 3.32%.


Green Plains Partners Acquires Abengoa Ethanol Storage Assets for $90M

The Deal:
Green Plains Partners LP (NASDAQ: GPP) announced Monday, that it acquired the ethanol storage assets associated with the Madison, IL, Mount Vernon, IN and York, NE production facilities from Green Plains Inc. (NASDAQ: GPRE) for $90 million. The storage assets were simultaneously purchased and sold by Green Plains as part of the $237 million purchase of three ethanol plants previously owned by Abengoa Bioenergy.

Green Plains Partners closed at $19.12 on Monday, down 1.29%.


CBOE Holdings to Acquire Bats Global Markets for $32.50/Share

The Deal:
CBOE Holdings, Inc. (NASDAQ: CBOE) and Bats Global Markets, Inc. (NASDAQ: BATS) announced Monday, that they have entered into a definitive agreement under which CBOE Holdings will acquire Bats for approximately $32.50 per Bats share, for a total of approximately $3.2 billion. Bats shareholders will receive $10.00 per share in cash and 0.3201 of a share of CBOE Holdings common stock. The transaction is expected to close in H1 of 2017.

Bats closed at $30.35 on Monday, down 4.56%.

Mylan, Lupin Said to be Considering Bids for Bayer's Dermatology Unit 

The Rumor:
Mylan NV (NYSE: MYL) and Lupin Ltd. are among the companies considering bidding for Bayer’s (OTC: BAYRY) dermatology business, according to sources as reported by Bloomberg on Monday. Bayer is selling the unit in order to raise cash ahead of its acquisition of Monsanto (NYSE: MON). Bayer and Lupin declined comment, while Mylan did not immediately respond.

Mylan closed at $41.18 on Monday, down 2.09%.


Related Articles (BAYRY + BATS)

View Comments and Join the Discussion!

Posted-In: M&A News Rumors Movers